TickerFactsScreenerDevelopers

Matinas BioPharma Holdings, Inc. (MTNB) — Net Income

Annual figures by fiscal year, from SEC filings.

2013: -$3.71M2014: -$10.22M2015: -$9.14M2016: -$7.60M2017: -$15.49M2018: -$14.08M2019: -$17.37M2020: -$22.45M2021: -$23.28M2022: -$21.00M2023: -$22.94M2024: -$24.25M2025: -$10.35M-$10.35M
2013Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$10.35M+57.3%
2024-$24.25M-5.7%
2023-$22.94M-9.3%
2022-$21.00M+9.8%
2021-$23.28M-3.7%
2020-$22.45M-29.2%
2019-$17.37M-23.4%
2018-$14.08M+9.1%
2017-$15.49M-103.8%
2016-$7.60M+16.8%
2015-$9.14M+10.6%
2014-$10.22M-175.3%
2013-$3.71M—